微生物鑑定市场规模、份额和成长分析(按产品/服务、方法、技术、应用、最终用户和地区划分)-2026-2033年产业预测
市场调查报告书
商品编码
1897856

微生物鑑定市场规模、份额和成长分析(按产品/服务、方法、技术、应用、最终用户和地区划分)-2026-2033年产业预测

Microbial Identification Market Size, Share, and Growth Analysis, By Product & Service (Instruments & Software, Consumables, Panels/Id Cards & Media), By Method, By Technology, By Application, By End User, By Region - Industry Forecast 2026-2033

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格
简介目录

全球微生物鑑定市场规模预计在 2024 年达到 50.6 亿美元,从 2025 年的 56.9 亿美元增长到 2033 年的 144.9 亿美元,在预测期(2026-2033 年)内复合年增长率为 12.4%。

全球微生物鑑定市场受感染疾病流行趋势和分子诊断技术进步的驱动,使其成为诊断和微生物学领域的关键组成部分。全球化、都市化和气候变迁等因素促使人们对高效微生物鑑定技术的需求不断增长。次世代定序、PCR和质谱等创新技术提高了鑑定的准确性和速度,进一步推动了市场扩张。卫生部门日益增强的意识和支持凸显了感染疾病防治的重要性,从而确保了相关措施所需的资金和资源。然而,高昂的前期成本、复杂的微生物鑑定程序和严格的监管要求等挑战可能会阻碍市场成长,尤其是在发展中地区。儘管如此,就地检验的进步、人工智慧的整合以及新兴研究市场需求的成长,正在创造新的成长机会。

全球微生物鑑定市场驱动因素

食源性疾病和感染疾病的日益增加凸显了严格食品安全通讯协定的重要性。因此,监管机构正强制要求食品生产商和製造商实施严格的微生物检测标准和规范。这种对食品安全的日益重视正在推动食品饮料行业的市场扩张。为了满足不断增长的安全需求,企业更加重视采用全面的微生物鑑定技术,从而促进了全球微生物鑑定市场的创新和成长。持续改进食品安全措施的努力不断塑造产业实践,并推动市场发展。

限制全球微生物鑑定市场的因素

微生物鑑定和表征面临许多挑战,需要专业的知识和技能。这种固有的复杂性使得许多实验室和医疗机构对采用先进的系统和技术犹豫不决,尤其是在资源有限、技术培训不足的地区。因此,缺乏先进工具和熟练人员可能会阻碍该领域创新技术的广泛应用,进而威胁到全球微生物鑑定市场的扩张。因此,克服这些障碍对于促进微生物鑑定实践的成长至关重要。

全球微生物鑑定市场趋势

在次世代定序和聚合酵素链锁反应(PCR) 等技术进步的推动下,快速分子诊断方法的应用已成为全球微生物鑑定市场的一大趋势。这项转变凸显了快速且准确地鑑定病原体的重要性,使医疗专业人员能够及时做出明智的治疗决策。与传统的培养方法相比,这些分子技术具有更高的灵敏度和更快的检测速度,透过早期诊断改善患者预后。随着医疗保健产业将精准医疗置于优先地位并不断提高诊断效率,对创新型微生物鑑定解决方案的需求预计将显着增长,从而重塑市场格局。

目录

介绍

  • 调查目标
  • 定义
  • 市场覆盖范围

调查方法

  • 资讯收集
  • 二手和一手资料资讯来源
  • 市场规模预测
  • 市场假设与限制

执行摘要

    前景
  • 供需趋势分析
  • 细分市场机会分析

市场动态与展望

  • 市场动态
    • 司机
    • 机会
    • 抑制因素
    • 任务
  • 波特分析

关键市场考察

  • 技术分析
  • 价值链分析
  • 市场生态系统
  • 供应链分析
  • 案例研究分析
  • 监管环境
  • 创新矩阵
  • 主要投资分析
  • 关键成功因素
  • 竞争程度

微生物鑑定市场(按产品/服务划分)

  • 设备和软体
  • 消耗品
    • 面板/ID卡和培养基
    • 成套工具
    • 其他消耗品
  • 服务

依方法分類的微生物鑑定市场

  • 表型法
  • 基于蛋白质体学的方法
  • 基因分型方法

按技术分類的微生物鑑定市场

  • 基于质谱的微生物鑑定市场
  • 基于PCR的微生物鑑定市场
  • 基于流式细胞技术的微生物鑑定市场
  • 基于显微镜的微生物鑑定市场
  • 其他微生物鑑定技术

微生物鑑定市场依应用领域划分

  • 诊断用途
    • 人类疾病诊断
    • 动物疾病诊断
  • 药物用途
  • 食品检验
  • 饮料检验
  • 化妆品和个人保健产品测试
  • 环境应用
  • 其他用途

按最终用户分類的微生物鑑定市场

  • 医院、诊断检查室和血库
  • 製药公司和合约研究组织
  • 食品製造公司
  • 饮料製造公司
  • 其他最终用户

微生物鑑定市场:按地区分類的市场规模:

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地区
  • 中东和非洲(MEA)
    • 海湾合作委员会国家
    • 南非
    • 其他中东和非洲地区

竞争格局

  • 前五大公司对比
  • 主要企业的市场定位(2025 年)
  • 主要市场参与者所采取的策略
  • 近期市集活动
  • 主要企业市占率(2025 年)

主要企业简介

  • BioMerieux SA(France)
  • Becton, Dickinson and Company(BD)(US)
  • Thermo Fisher Scientific Inc.(US)
  • Danaher Corporation(US)
  • Merck KGaA(Germany)
  • Bruker Corporation(US)
  • Shimadzu Corporation(Japan)
  • Qiagen NV(Netherlands)
  • Avantor, Inc.(US)
  • Accelerate Diagnostics, Inc.(US)
  • Biolog, Inc.(US)
  • Liofilchem Srl(Italy)
  • Trivitron Healthcare(India)
  • Gradian Diagnostics(US)
  • Alifax Srl(Italy)
  • HiMedia Laboratories(India)
  • i2a SA(France)
  • Zhuhai DL Biotech Co., Ltd.(China)
  • GeneFluidics, Inc.(US)
  • Creative Diagnostics(US)
简介目录
Product Code: SQMIG35J2067

Global Microbial Identification Market size was valued at USD 5.06 Billion in 2024 and is poised to grow from USD 5.69 Billion in 2025 to USD 14.49 Billion by 2033, growing at a CAGR of 12.4% during the forecast period (2026-2033).

The global microbial identification market represents a crucial sector within diagnostics and microbiology, driven by an increasing prevalence of infectious diseases and advancements in molecular diagnostics. Factors such as globalization, urbanization, and climate change contribute to rising demand for effective microbial identification technologies. Innovations like next-generation sequencing, PCR, and mass spectrometry enhance accuracy and speed, further propelling market expansion. Increased awareness and support from health organizations highlight the importance of controlling infectious diseases, leading to necessary funding and resources for relevant initiatives. However, challenges such as high initial costs, complexity in microbial identification procedures, and stringent regulatory requirements could hinder market growth, particularly in developing regions. Nevertheless, growth opportunities emerge through advancements in point-of-care testing and AI integration, coupled with rising demand in emerging research markets.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Microbial Identification market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Microbial Identification Market Segments Analysis

Global Microbial Identification Market is segmented by Product & Service, Method, Technology, Application, End User, and region. Based on Product & Service, the market is segmented into Instruments & Software, Consumables, and Services. Based on Method, the market is segmented into Phenotypic Methods, Proteomics-Based Methods, and Genotypic Methods. Based on Technology, the market is segmented into Mass Spectrometry-Based Microbial Identification Market, PCR Based Microbial Identification Market, Flow Cytometry Based Microbial Identification Market, Microscopy Based Microbial Identification Market, and Other Microbial Identification Technologies. Based on Application, the market is segmented into Diagnostic Applications Pharmaceutical Applications, Food Testing, Beverage Testing, Cosmetics and Personal Care Products Testing, Environmental Applications, and Other Applications. Based on End User, the market is segmented into Hospitals, Diagnostic Laboratories, and Blood Banks, Pharmaceutical Companies & Contract Research Organizations, Food Manufacturing Companies, Beverage Manufacturing Companies, and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Microbial Identification Market

The increasing incidence of foodborne illnesses and infections has heightened the emphasis on stringent food safety protocols. As a result, regulatory agencies are urging food producers and manufacturers to implement rigorous microbial testing standards and practices. This heightened focus on ensuring food safety is propelling market expansion within the food and beverage sector. Companies are becoming more vigilant in adopting comprehensive microbial identification techniques to meet these elevated safety demands, thus fostering innovation and growth in the global microbial identification market. The ongoing commitment to improving food safety measures continues to shape industry practices and drive market development.

Restraints in the Global Microbial Identification Market

The identification and characterization of microorganisms presents significant challenges that require specialized expertise and skills. This inherent complexity can deter many laboratories and healthcare providers from embracing advanced systems and technologies, particularly in areas with limited resources and inadequate technical training. Consequently, these issues can impede the expansion of the Global Microbial Identification market, as the lack of accessibility to advanced tools and the need for skilled personnel may hinder widespread adoption and utilization of innovation in the field. As a result, overcoming these barriers becomes essential for fostering growth and enhancing microbial identification practices.

Market Trends of the Global Microbial Identification Market

The global microbial identification market is witnessing a significant trend towards the adoption of rapid molecular diagnostics, propelled by advancements in technologies such as next-generation sequencing and polymerase chain reaction (PCR). This shift emphasizes the need for swift and accurate identification of pathogens, enabling healthcare providers to make timely and informed treatment decisions. These molecular techniques offer superior sensitivity and faster turnaround times compared to traditional culture-based methods, enhancing patient outcomes through early diagnosis. As healthcare continues to prioritize precision medicine and improve diagnostic efficiency, the demand for innovative microbial identification solutions is expected to increase significantly, transforming the market landscape.

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Technology Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • Supply chain Analysis
  • Case study Analysis
  • Regulatory Landscape
  • Innovation Matrix
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Microbial Identification Market by Product & Service

  • Market Overview
  • Instruments & Software
  • Consumables
    • Panels/Id Cards & Media
    • Kits
    • Other Consumables
  • Services

Microbial Identification Market by Method

  • Market Overview
  • Phenotypic Methods
  • Proteomics-Based Methods
  • Genotypic Methods

Microbial Identification Market by Technology

  • Market Overview
  • Mass Spectrometry-Based Microbial Identification Market
  • PCR Based Microbial Identification Market
  • Flow Cytometry Based Microbial Identification Market
  • Microscopy Based Microbial Identification Market
  • Other Microbial Identification Technologies

Microbial Identification Market by Application

  • Market Overview
  • Diagnostic Applications
    • Human Disease Diagnosis
    • Animal Disease Diagnosis
  • Pharmaceutical Applications
  • Food Testing
  • Beverage Testing
  • Cosmetics And Personal Care Products Testing
  • Environmental Applications
  • Other Applications

Microbial Identification Market, By End User

  • Hospitals, Diagnostic Laboratories, and Blood Banks
  • Pharmaceutical Companies & Contract Research Organizations
  • Food Manufacturing Companies
  • Beverage Manufacturing Companies
  • Other End Users

Microbial Identification Market Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2025

Key Company Profiles

  • BioMerieux SA (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton, Dickinson and Company (BD) (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danaher Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bruker Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Shimadzu Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Qiagen NV (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Avantor, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Accelerate Diagnostics, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biolog, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Liofilchem S.r.l. (Italy)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Trivitron Healthcare (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Gradian Diagnostics (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Alifax S.r.l. (Italy)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • HiMedia Laboratories (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • i2a SA (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zhuhai DL Biotech Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GeneFluidics, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Creative Diagnostics (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments